SBH Sciences Inc

SBH Sciences Inc. is a preclinical contract research organization (CRO) based in Natick, Massachusetts. The company employs 19 people and has generated over $10,000 in revenue. SBH Sciences specializes in supporting the development of anti-cancer and anti-inflammation drugs. They offer a range of services to early-stage biotechnology companies, including incubator-model support, cell-based discovery, cytokine and enzyme production, immunological and analytical services. Their extensive portfolio includes over 330 cytokine bioassays, making it the most comprehensive collection in the United States. The company distinguishes itself through its comprehensive suite of services, which encompass cytotoxicity testing, biomarker measurement, functional activity testing, in-vivo modeling, diagnostics, and kinase screening. SBH Sciences boasts a collection of over 370 human cancer cell lines for in-vitro oncology lead drug screening. They also offer an 11 biomarker platform featuring advanced technologies such as fully automatic ELISA workstations, Luminex, Western Blot systems, ELLA, MSD, HTRF, Alpha-Lisa, FACS, Iso-Light, HPLC, and qRT-PCR. For more information about SBH Sciences Inc. and their services, please visit their website at http://sbhsciences.com/.